ABBV
coming into some major support here: A descending TL from ATH that was resistance before
2 year volume shelf starting at 155
200SMA on daily
waiting to see how it reacts
* long above 160 & hold on daily
* not willing to short it
key points:
* Humira sales declining further as more competition mounts
* Other drug sales increase compensating somewhat for the Humira decline